Triple

T789408
Position Surface form Disambiguated ID Type / Status
Subject National Center for Advancing Translational Sciences E16877 entity
Predicate hasPart P35 FINISHED
Object Office of Rare Diseases Research
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
E93883 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Office of Rare Diseases Research | Statement: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Office of Rare Diseases Research
Context triple: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
  • A. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • B. National Institute of Child Health and Human Development
    The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
  • C. National Human Genome Research Institute
    The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
  • D. National Institute of Arthritis and Musculoskeletal and Skin Diseases
    The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
  • E. National Institute of General Medical Sciences
    The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Office of Rare Diseases Research
Triple: [National Center for Advancing Translational Sciences, hasPart, Office of Rare Diseases Research]
Generated description
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Office of Rare Diseases Research
Target entity description: The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
  • A. National Center for Advancing Translational Sciences
    The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
  • B. National Institute of Child Health and Human Development
    The National Institute of Child Health and Human Development is a U.S. federal biomedical research institute that focuses on understanding human development, improving reproductive health, and enhancing the lives of children and families.
  • C. National Human Genome Research Institute
    The National Human Genome Research Institute is a U.S. government biomedical research organization that leads and funds research on the structure, function, and impact of the human genome.
  • D. National Institute of Arthritis and Musculoskeletal and Skin Diseases
    The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
  • E. National Institute of General Medical Sciences
    The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a4936cb7448190914f5fe4b8d81607 completed March 1, 2026, 7:28 p.m.
NER Named-entity recognition batch_69a4a7841b0c8190859ecd247e32c6ec completed March 1, 2026, 8:54 p.m.
NED1 Entity disambiguation (via context triple) batch_69a6787eac608190acc40d56f827284e completed March 3, 2026, 5:58 a.m.
NEDg Description generation batch_69a67a663f6c819084b5dffdde3531aa completed March 3, 2026, 6:06 a.m.
NED2 Entity disambiguation (via description) batch_69a67b1d50b0819088232ad797babced completed March 3, 2026, 6:09 a.m.
Created at: March 1, 2026, 7:38 p.m.